查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828219

2025年粒子治療全球市場報告

Particle Therapy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，粒子治療市場規模迅速擴張，從2024年的12.3億美元成長到2025年的13.6億美元，複合年成長率達11.0%。這段歷史時期的成長可歸因於臨床研究和調查、癌症發生率的上升、政府支持和資金投入、產業合作以及治療方案的改進。

預計未來幾年粒子治療市場規模將快速成長，到2029年將達到21.6億美元，複合年成長率為12.3%。預測期內的成長可歸因於醫療保健支出的增加、新興的非腫瘤學應用、老年人口的成長、醫療保健基礎設施的發展以及人工智慧和數據分析的融合。預測期內的主要趨勢包括粒子加速器技術的進步、低分次技術、聯合治療、患者舒適度的提高以及生物主導的治療通訊協定。

粒子治療是一種先進的癌症治療方法，它利用帶電粒子（例如質子和重離子）將放射治療直接傳送到癌症腫瘤。這種治療方法主要利用高能量電離粒子瞄準腫瘤部位，旨在改善各種腫瘤患者的預後，尤其是那些難以用常規放射療法治療的腫瘤患者。

粒子治療治療方法分為兩種：質子治療和重離子治療。質子治療是一種專門用於癌症治療的放射治療。質子治療適用於單室和多室系統，應用範圍廣泛。質子治療可用於治療多種癌症，包括但不限於兒童癌症、攝護腺癌、肺癌、乳癌以及腦部和脊髓癌。粒子治療的主要終端使用者是醫院、學術機構和研究中心。粒子治療為癌症治療提供了一種有針對性的精準方法，最大限度地減少了對周圍健康組織的損傷，並增強了放射治療的效果。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供粒子治療市場統計數據，例如粒子治療行業的全球市場規模、各地區市場佔有率、各競爭對手的市場佔有率、詳細的粒子治療細分市場、市場趨勢和商業機會，以及在粒子治療行業取得成功所需的數據。本粒子治療市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的全方位觀點。

未來五年的預測成長率為12.3%，較我們先前對該市場的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。這種影響可能會直接影響美國，因為超導性迴旋加速器磁鐵和束流引導系統（主要由比利時和義大利供應）的成本上升，從而影響美國先進的癌症治療中心的運作。由於互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響，這種影響也將更加廣泛。

癌症發生率的上升預計將推動未來粒子治療市場的成長。癌症是一類複雜多樣的疾病，其特徵是體內細胞的異常生長和增生。粒子治療透過將帶正電的粒子（質子）加速到高速，聚焦於腫瘤並進行精確的放射治療，從而有效地治療癌症。例如，總部位於法國的政府間組織國際癌症研究機構（IARC）於2024年4月報告稱，2022年全球將新增約2,000萬例癌症病例，約1,000萬人死亡。根據人口趨勢預測，到2050年，全球新增癌症病例可能達到每年3,500萬例，比2022年增加77%。因此，癌症發生率的上升是推動粒子治療市場成長的關鍵因素。

預計人口老化將在未來幾年推動粒子治療市場的成長。老化是指社會中老年人比例不斷增加的人口結構變化。粒子治療對老年人尤其有益，因為它可以精準、有針對性地治療癌症，最大限度地減少對周圍健康組織的損害，降低長期副作用的風險，從而提高接受癌症治療的老年患者的生活品質。例如，總部位於肯亞的非營利人口研究所在2024年1月估計，到2050年，65歲及以上的美國人口數量將增加47%，從2022年的5,800萬增加到8,200萬人。預計同期該年齡層人口占總人口的比例也將從17%增加到23%。因此，老化是粒子治療市場的主要驅動力。

先進的粒子治療平台正成為粒子治療市場的關鍵趨勢。該領域的主要參與者正致力於開發創新的粒子治療解決方案，以保持競爭力。例如，2023年7月，瑞典醫療科技公司RaySearch Laboratories推出了RayStation 2023B。這款全面的腫瘤治療計劃系統融合了粒子治療領域的多項突破性進展，包括支持離散質子弧和基於線性能量轉移（LET）的穩健最佳化。 LET最佳化旨在透過將高LET粒子靶向腫瘤，從而最大限度地減少潛在的副作用，從而改善腫瘤控制，同時降低危及器官的LET。此外，離散質子弧最佳化可實現更大的射束角度範圍，從而實現更適形的劑量分佈，並減少敏感器官的暴露。該軟體還可以輕鬆轉換為標準筆射束掃描計劃，為光子治療提供自動化的場內規劃，為近距離放射治療提供基於點的最佳化，並加快數據加載速度。

為了獲得競爭優勢，粒子治療市場的主要企業正在加緊努力開發創新治療方法，尤其是質子治療解決方案。質子治療技術是一種先進的癌症治療方法，它利用質子和帶正電的粒子向癌細胞提供精確的標靶輻射。例如，2023 年 4 月，以色列高科技公司 P-Cure 的自適應質子治療解決方案獲得美國食品藥物管理局(USFDA) 的批准，允許其在美國銷售。這種經濟實惠的質子治療技術旨在進行標靶癌症治療，並顯著減少與治療相關的副作用。 P-Cure 的創新直立解決方案是世界上第一個獲得 FDA核准的患者定位技術，可在坐姿下進行治療，從而提高患者的舒適度和臨床效果。

2022年5月，總部位於德國的醫療科技公司Brainlab AG收購了medPhoton GmbH的多數股權，收購金額未揭露。此次策略性收購旨在擴展Brainlab的術中成像產品組合，推動業務成長，加強產品開發，並加速這一重要醫療技術領域的創新。 medPhoton GmbH是一家總部位於奧地利的醫療設備製造商，專門提供粒子束治療設備和服務。

粒子治療市場涵蓋提供粒子治療服務的營業單位所獲得的收益，這些服務包括治療計劃、粒子輸送、成像和模擬、治療療程、病患監測以及支援服務。市場價值還包括服務提供者銷售或包含在服務產品中的相關商品的價值。僅包括營業單位之間交易或銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球粒子療法：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球粒子治療市場：成長率分析
  • 全球粒子治療市場表現：規模與成長，2019-2024
  • 全球粒子治療市場預測：規模與成長，2024-2029年，2034年
  • 全球粒子治療：總目標市場（TAM）

第6章 市場細分

  • 全球粒子治療市場：依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 質子治療
  • 重粒子線治療
  • 全球粒子治療市場：按系統、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 單室系統
  • 多房間系統
  • 全球粒子治療市場（按癌症類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 兒童癌症
  • 攝護腺癌
  • 肺癌
  • 乳癌
  • 腦癌和脊髓癌
  • 其他類型的癌症
  • 全球粒子治療市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 學術研究中心
  • 全球粒子治療市場：依質子治療類型、績效及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 筆射束掃描質子治療
  • 被動散射質子治療
  • 調強質子治療（IMPT）
  • 全球粒子治療市場：重離子治療細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 碳離子療法
  • 氦離子療法
  • 其他重離子

第7章 區域和國家分析

  • 全球粒子治療市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球粒子治療市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 粒子束治療市場：競爭格局
  • 粒子治療市場：公司簡介
    • Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Mitsubishi Electric Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems Inc.
  • Elekta AB
  • Shinva Medical Instrument Co. Ltd.
  • Toshiba Medical Systems Corporation
  • Brainlab AG
  • Accuray Incorporated
  • IBA Worldwide
  • Mevion Medical Systems Inc.
  • Avante Health Solutions
  • Provision Healthcare LLC
  • ViewRay
  • Panacea Biotec Ltd.
  • PTW Freiburg GmbH.
  • ProNova Solutions LLC

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年粒子治療市場：提供新機會的國家
  • 2029年粒子治療市場：細分領域帶來新機會
  • 2029年粒子治療市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r25184u

Particle therapy is an advanced cancer treatment that employs charged particles, such as protons or heavier ions, to administer radiation therapy directly to cancerous tumors. This method primarily targets energetic ionizing particles at the tumor location, aiming to improve treatment outcomes for patients with various types of tumors, particularly those that are difficult to treat using conventional radiation therapy.

Two primary types of therapies fall under the umbrella of particle therapy, proton therapy and heavy ion therapy. Proton therapy is a specialized form of radiation therapy employed in cancer treatment. It encompasses both single-room systems and multi-room systems, providing versatility in its application. Proton therapy is utilized for the treatment of various cancers, including but not limited to pediatric cancer, prostate cancer, lung cancer, breast cancer, and cancers affecting the brain and spinal cord. The primary end users of particle therapy are hospitals, academic institutions, and research centers. Particle therapy offers a targeted and precise approach to cancer treatment, minimizing damage to surrounding healthy tissues and enhancing the therapeutic effectiveness of radiation.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The particle therapy market research report is one of a series of new reports from The Business Research Company that provides particle therapy market statistics, including particle therapy industry global market size, regional shares, competitors with a particle therapy market share, detailed particle therapy market segments, market trends and opportunities, and any further data you may need to thrive in the particle therapy industry. This particle therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The particle therapy market size has grown rapidly in recent years. It will grow from $1.23 billion in 2024 to $1.36 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to clinical research and studies, increased cancer incidence, government support and funding, industry collaboration, and improvements in treatment planning.

The particle therapy market size is expected to see rapid growth in the next few years. It will grow to $2.16 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing healthcare expenditure, emerging applications beyond cancer, a rise in the geriatric population, healthcare infrastructure development, AI and data analytics integration. Major trends in the forecast period include advancements in particle accelerator technology, hypofractionation techniques, proton and carbon ion combination therapy, improved patient comfort, and biology-driven treatment protocols.

The forecast of 12.3% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through higher costs for superconducting cyclotron magnets and beam guidance systems, predominantly supplied by Belgium and Italy, impacting advanced cancer treatment center operations.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cancer is anticipated to drive the growth of the particle therapy market in the future. Cancer is a complex and varied group of diseases marked by the abnormal growth and multiplication of cells in the body. Particle therapy effectively treats cancer through precise radiation delivery, utilizing positively charged particles (protons) that are accelerated to high speeds and focused on the tumor. For instance, in April 2024, the International Agency for Research on Cancer (IARC), a France-based intergovernmental agency, reported that nearly 20 million new cancer cases were recorded in 2022, resulting in almost 10 million deaths. Projections based on demographic trends indicate that the annual incidence of new cancer cases could reach 35 million by 2050, representing a 77% increase from the 2022 figures. Therefore, the rising prevalence of cancer is a key factor driving the growth of the particle therapy market.

The increasing aging population is projected to contribute to the growth of the particle therapy market in the coming years. An aging population refers to a demographic shift characterized by a growing proportion of elderly individuals within a society. Particle therapy is particularly beneficial for the geriatric population as it offers a precise and targeted approach to cancer treatment, minimizing damage to surrounding healthy tissues and reducing the risk of long-term side effects, thereby enhancing the quality of life for older patients receiving cancer therapy. For example, in January 2024, the Population Reference Bureau, a Kenya-based nonprofit organization, estimated that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. This age group's share of the total population is also expected to grow from 17% to 23% during the same period. Thus, the aging population is a significant driver of the particle therapy market.

Advanced particle therapy platforms are becoming a significant trend in the particle therapy market. Key players in this field are focusing on developing innovative particle therapy solutions to maintain their competitive edge. For example, in July 2023, RaySearch Laboratories, a Sweden-based medical technology firm, introduced RayStation 2023B. This comprehensive oncology treatment planning system incorporates several groundbreaking advancements in particle therapy, including support for discrete proton arcs and robust optimization based on linear energy transfer (LET). LET optimization aims to minimize potential side effects by reducing LET in at-risk organs while directing high LET particles to tumors for better tumor control. Additionally, discrete proton arc optimization allows for a wider range of beam angles, resulting in more conformal dose distributions and less exposure for sensitive organs. The software also offers easy conversion to standard pencil-beam scanning plans, automatic field-in-field planning for photon treatments, point-based optimization for brachytherapy, and improved data loading speeds.

Key companies in the particle therapy market are intensifying their efforts to develop innovative therapies, with a particular focus on proton therapy solutions, to gain a competitive advantage. Proton therapy technology, a sophisticated form of cancer treatment utilizing protons and positively charged particles, delivers precise and targeted radiation to cancer cells. For instance, in April 2023, P-Cure, an Israel-based high-med-tech company, obtained clearance from the United States Food and Drug Administration (USFDA) for its Adaptive Proton Therapy Solution, allowing sales in the USA. This affordable proton therapy technology is designed for targeted cancer treatment with significantly reduced treatment-related side effects. P-Cure's innovative upright solution, the world's first FDA-approved methodology for patient positioning, enables seated treatment, enhancing both patient comfort and clinical outcomes.

In May 2022, Brainlab AG, a Germany-based medical technology company, acquired a majority stake in medPhoton GmbH for an undisclosed amount. This strategic acquisition aims to expand Brainlab's intraoperative imaging portfolio, drive business growth, bolster product development, and accelerate innovation in the critical field of medical technology. medPhoton GmbH, an Austria-based medical equipment manufacturing company, specializes in providing particle therapy devices and services.

Major companies operating in the particle therapy market include Hitachi Ltd., Mitsubishi Electric Corporation, Siemens Healthineers AG, Koninklijke Philips N.V, GE Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Shinva Medical Instrument Co. Ltd., Toshiba Medical Systems Corporation, Brainlab AG, Accuray Incorporated, IBA Worldwide, Mevion Medical Systems Inc., Avante Health Solutions, Provision Healthcare LLC, ViewRay, Panacea Biotec Ltd., PTW Freiburg GmbH., ProNova Solutions LLC, Optivus Proton Therapy Inc., Xstrahl Inc., Protom International Inc., Danfysik AS, SAH Global LLC, Advanced Oncotherapy plc, Particle Therapy Co-Operative Group, Best Particle Therapy Inc.

North America was the largest region in the particle therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the particle therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The particle therapy market includes of revenues earned by entities by providing particle therapy services such as treatment planning, particle beam delivery, imaging and simulation, treatment sessions, patient monitoring, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Particle Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on particle therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for particle therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The particle therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Proton Therapy; Heavy Ion Therapy
  • 2) By System: Single-Room Systems; Multi-Room Systems
  • 3) By Cancer Type: Pediatric Cancer; Prostate Cancer; Lung Cancer; Breast Cancer; Brain And Spinal Cord Cancer; Other Cancer Types
  • 4) By End-User: Hospital; Academic And Research Centers
  • Subsegments:
  • 1) By Proton Therapy: Pencil Beam Scanning Proton Therapy; Passive Scattering Proton Therapy; Intensity-Modulated Proton Therapy (IMPT)
  • 2) By Heavy Ion Therapy: Carbon Ion Therapy; Helium Ion Therapy; Other Heavy Ions
  • Companies Mentioned: Hitachi Ltd.; Mitsubishi Electric Corporation; Siemens Healthineers AG; Koninklijke Philips N.V; GE Healthcare; Sumitomo Heavy Industries Ltd.; Varian Medical Systems Inc.; Elekta AB; Shinva Medical Instrument Co. Ltd.; Toshiba Medical Systems Corporation; Brainlab AG; Accuray Incorporated; IBA Worldwide; Mevion Medical Systems Inc.; Avante Health Solutions; Provision Healthcare LLC; ViewRay; Panacea Biotec Ltd.; PTW Freiburg GmbH.; ProNova Solutions LLC; Optivus Proton Therapy Inc.; Xstrahl Inc.; Protom International Inc.; Danfysik AS; SAH Global LLC; Advanced Oncotherapy plc; Particle Therapy Co-Operative Group; Best Particle Therapy Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Particle Therapy Market Characteristics

3. Particle Therapy Market Trends And Strategies

4. Particle Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Particle Therapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Particle Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Particle Therapy Market Growth Rate Analysis
  • 5.4. Global Particle Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Particle Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Particle Therapy Total Addressable Market (TAM)

6. Particle Therapy Market Segmentation

  • 6.1. Global Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Proton Therapy
  • Heavy Ion Therapy
  • 6.2. Global Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Room Systems
  • Multi-Room Systems
  • 6.3. Global Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pediatric Cancer
  • Prostate Cancer
  • Lung Cancer
  • Breast Cancer
  • Brain And Spinal Cord Cancer
  • Other Cancer Types
  • 6.4. Global Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Academic And Research Centers
  • 6.5. Global Particle Therapy Market, Sub-Segmentation Of Proton Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pencil Beam Scanning Proton Therapy
  • Passive Scattering Proton Therapy
  • Intensity-Modulated Proton Therapy (IMPT)
  • 6.6. Global Particle Therapy Market, Sub-Segmentation Of Heavy Ion Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Carbon Ion Therapy
  • Helium Ion Therapy
  • Other Heavy Ions

7. Particle Therapy Market Regional And Country Analysis

  • 7.1. Global Particle Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Particle Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Particle Therapy Market

  • 8.1. Asia-Pacific Particle Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Particle Therapy Market

  • 9.1. China Particle Therapy Market Overview
  • 9.2. China Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Particle Therapy Market

  • 10.1. India Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Particle Therapy Market

  • 11.1. Japan Particle Therapy Market Overview
  • 11.2. Japan Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Particle Therapy Market

  • 12.1. Australia Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Particle Therapy Market

  • 13.1. Indonesia Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Particle Therapy Market

  • 14.1. South Korea Particle Therapy Market Overview
  • 14.2. South Korea Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Particle Therapy Market

  • 15.1. Western Europe Particle Therapy Market Overview
  • 15.2. Western Europe Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Particle Therapy Market

  • 16.1. UK Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Particle Therapy Market

  • 17.1. Germany Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Particle Therapy Market

  • 18.1. France Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Particle Therapy Market

  • 19.1. Italy Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Particle Therapy Market

  • 20.1. Spain Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Particle Therapy Market

  • 21.1. Eastern Europe Particle Therapy Market Overview
  • 21.2. Eastern Europe Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Particle Therapy Market

  • 22.1. Russia Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Particle Therapy Market

  • 23.1. North America Particle Therapy Market Overview
  • 23.2. North America Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Particle Therapy Market

  • 24.1. USA Particle Therapy Market Overview
  • 24.2. USA Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Particle Therapy Market

  • 25.1. Canada Particle Therapy Market Overview
  • 25.2. Canada Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Particle Therapy Market

  • 26.1. South America Particle Therapy Market Overview
  • 26.2. South America Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Particle Therapy Market

  • 27.1. Brazil Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Particle Therapy Market

  • 28.1. Middle East Particle Therapy Market Overview
  • 28.2. Middle East Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Particle Therapy Market

  • 29.1. Africa Particle Therapy Market Overview
  • 29.2. Africa Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Particle Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Particle Therapy Market Competitive Landscape
  • 30.2. Particle Therapy Market Company Profiles
    • 30.2.1. Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Mitsubishi Electric Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips N.V Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis

31. Particle Therapy Market Other Major And Innovative Companies

  • 31.1. Sumitomo Heavy Industries Ltd.
  • 31.2. Varian Medical Systems Inc.
  • 31.3. Elekta AB
  • 31.4. Shinva Medical Instrument Co. Ltd.
  • 31.5. Toshiba Medical Systems Corporation
  • 31.6. Brainlab AG
  • 31.7. Accuray Incorporated
  • 31.8. IBA Worldwide
  • 31.9. Mevion Medical Systems Inc.
  • 31.10. Avante Health Solutions
  • 31.11. Provision Healthcare LLC
  • 31.12. ViewRay
  • 31.13. Panacea Biotec Ltd.
  • 31.14. PTW Freiburg GmbH.
  • 31.15. ProNova Solutions LLC

32. Global Particle Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Particle Therapy Market

34. Recent Developments In The Particle Therapy Market

35. Particle Therapy Market High Potential Countries, Segments and Strategies

  • 35.1 Particle Therapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Particle Therapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Particle Therapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer